Psychobiotics Adelaide: Gut-Brain Therapy for Mood

ByRohan Smith
Psychobiotics in Adelaide: Precision Gut-Brain Therapy for Mood

Author: Rohan Smith | Functional Medicine Practitioner | Adelaide, SA

Quick Answer

Psychobiotics are specific probiotic strains, such as Lactobacillus rhamnosus (JB-1) and Bifidobacterium longum (NCC3001), that may confer mental health benefits by modulating gut-brain axis signalling. Unlike general digestive probiotics, psychobiotics have been studied for their potential effects on neurotransmitter activity, hypothalamic-pituitary-adrenal (HPA) axis regulation, and immune-mediated inflammatory pathways associated with mood and cognition (1,2,3,15).

At a Glance

  • Psychobiotics are a defined subclass of probiotics researched for their influence on gut-brain axis communication, including vagus nerve signalling and neurotransmitter modulation (1,2).
  • Bifidobacterium longum NCC3001 has been associated with reduced depression scores and altered limbic brain activity in a human pilot study of irritable bowel syndrome patients (2,8).
  • Short-chain fatty acids (SCFAs) such as butyrate, produced by gut microbiota, may support blood-brain barrier integrity and brain-derived neurotrophic factor (BDNF) expression (9,13).
  • Tryptophan metabolism through the kynurenine pathway can be influenced by intestinal inflammation, potentially reducing serotonin availability and increasing neuroinflammatory metabolites like quinolinic acid (7,12).
  • Clinical and preclinical evidence suggests strain-specific effects; Lactobacillus helveticus R0052 has been studied for its association with cortisol regulation under stress (5,10).

The Science: The Gut-Brain Communication Network

The gut-brain axis is a bidirectional communication network involving the vagus nerve, enteric nervous system, immune mediators, and hypothalamic-pituitary-adrenal (HPA) axis signalling that connects intestinal microbiota with central nervous system function. For many Adelaide residents experiencing persistent anxiety, low mood, or cognitive symptoms, emerging research from institutions including University College Cork’s APC Microbiome Ireland suggests that gut microbiome composition may influence brain chemistry, stress physiology, and emotional resilience. At Elemental Health and Nutrition, psychobiotics are explored as part of a functional approach to gut-brain health.

This relationship sits within the broader context of gut microbiome and brain health, where microbial balance, barrier integrity, and immune signalling can influence brain-related symptoms.

Psychobiotics may interact with this system through several biological mechanisms, as outlined by researchers including Timothy Dinan and John Cryan in their foundational 2013 paper published in Biological Psychiatry (1):

Mechanism Key Details Evidence
Neurotransmitter Modulation Lactobacillus rhamnosus (JB-1) has demonstrated the ability in preclinical models to influence GABA receptor expression in brain regions associated with emotional regulation, including the amygdala and prefrontal cortex Bravo JA et al., PNAS (4,11)
Short-Chain Fatty Acids (SCFAs) Microbial fermentation of dietary fibre produces SCFAs such as butyrate, which support intestinal barrier integrity and are associated with brain-derived neurotrophic factor (BDNF) signalling relevant to learning and memory Bourassa MW et al., Neuroscience Letters (9,13)
HPA Axis Regulation Psychobiotics may influence hypothalamic-pituitary-adrenal (HPA) axis activity, with human and animal studies showing associations with altered cortisol responses under stress Sudo N et al., J Physiol; Messaoudi M et al., Br J Nutr (5,6)

The Kynurenine Pathway: Why Gut Health Influences Mood

Tryptophan, the essential amino acid precursor to serotonin (5-HT), may be preferentially metabolised through the kynurenine pathway during states of intestinal inflammation or immune activation. This metabolic shift, characterised by increased indoleamine 2,3-dioxygenase (IDO) enzyme activity, reduces tryptophan availability for serotonin synthesis while increasing production of metabolites such as quinolinic acid, which are associated with neuroinflammation, brain fog, and depressive symptoms (7,12).

By supporting gut barrier function and reducing inflammatory signalling mediated by cytokines such as interleukin-6 (IL-6) and tumour necrosis factor alpha (TNF-alpha), psychobiotics may help influence tryptophan metabolism toward pathways involved in serotonin and melatonin production, which are relevant to mood regulation and sleep physiology (12,14).

Strain-Specific Psychobiotics Studied for Mental Health

Psychobiotic effects are strain-specific, meaning benefits cannot be generalised across probiotic species or even between strains of the same species. Clinical and preclinical research has focused on a limited number of well-characterised organisms:

Strain Research Findings References
Bifidobacterium longum NCC3001 Human trials conducted by Pinto-Sanchez MI et al. at McMaster University demonstrated associations with reduced depression scores on the Hospital Anxiety and Depression Scale (HADS) and changes in limbic brain activity via fMRI in patients with irritable bowel syndrome (2,8)
Lactobacillus helveticus R0052 Studied by Messaoudi M et al. for its potential influence on urinary free cortisol levels and stress-related symptom patterns in healthy volunteers (5,10)
Bifidobacterium infantis 35624 Preclinical research by Desbonnet L et al. suggests regulatory effects on pro-inflammatory cytokine signalling and kynurenine pathway metabolism, with potential relevance to depression (7,15)

Clinical Integration in Adelaide

Functional medicine approaches to psychobiotic therapy require individualised assessment rather than empirical supplementation. Psychobiotics are not used as stand-alone interventions; within a functional framework at Elemental Health and Nutrition, they may be considered alongside diet, lifestyle, and broader gut health strategies informed by contextual functional assessments.

This can be particularly relevant where gut-brain symptoms overlap with chronic fatigue and mood disorders, where immune activation, sleep disruption, and cognitive symptoms may coexist.

Assessment Tool Purpose
GI-MAP Testing (Diagnostic Solutions Laboratory) Explores microbial balance patterns using quantitative PCR, including commensal bacteria, opportunistic organisms, and potential contributors to gut-mediated immune activation
Organic Acids Testing (OAT) Provides insight into metabolic by-products related to neurotransmitter metabolism (including homovanillic acid and vanillylmandelic acid) and microbial activity markers

These assessments are not diagnostic tools and are interpreted in clinical context to identify functional patterns rather than diagnose disease.

When to Consider Psychobiotics

Psychobiotics may be considered in individuals experiencing mood or cognitive symptoms alongside digestive disturbances, heightened stress reactivity, or signs of gut-immune dysregulation. Suitability depends on individual history, current treatment, and overall health context.

Next Steps

  1. Assess your gut-brain connection: If you experience mood, cognitive, or stress symptoms alongside digestive issues, a functional consultation can help determine whether gut-brain signalling is a contributing factor.
  2. Consider targeted testing: GI-MAP or Organic Acids Testing can provide insight into microbial balance, neurotransmitter metabolism, and immune activation patterns relevant to psychobiotic selection.
  3. Explore strain-specific support: Work with a qualified practitioner to identify whether specific psychobiotic strains align with your presentation and broader nutritional and lifestyle goals.

Frequently Asked Questions

Can psychobiotics be obtained from fermented foods?
Fermented foods such as kefir, yoghurt, and sauerkraut support general microbial diversity but typically do not contain the specific strains or dosages used in psychobiotic research (1,9).

How long does it take to notice changes?
Clinical trials examining mood-related outcomes often report changes within 4-8 weeks of consistent use, though responses vary between individuals (2,5).

Can psychobiotics replace antidepressant medication?
Psychobiotics are not a replacement for prescribed medication. They are best viewed as a complementary strategy that may be explored under practitioner guidance as part of an integrative care plan (8,10).

Key Insights

  • Psychobiotics are probiotic strains researched for their effects on gut-brain signalling pathways (1,2).
  • They may influence neurotransmitter activity, SCFA production, and stress-response physiology (3,11).
  • Strain selection matters — effects are not interchangeable across probiotic species (5,8).
  • Individualised assessment helps determine whether psychobiotic strategies are appropriate (11,15).

Citable Takeaways

  1. Bifidobacterium longum NCC3001 was associated with reduced depression scores and altered limbic brain activity on fMRI in a pilot study of IBS patients, as reported by Pinto-Sanchez MI et al. in Gastroenterology (2017) (2).
  2. Timothy Dinan and John Cryan defined psychobiotics as a novel class of psychotropic microorganisms that may confer mental health benefits when administered in adequate amounts, per their 2013 paper in Biological Psychiatry (1).
  3. Lactobacillus rhamnosus (JB-1) ingestion altered GABA receptor expression in the amygdala and prefrontal cortex in a vagus nerve-dependent manner in preclinical models, as demonstrated by Bravo JA et al. in PNAS (2011) (4).
  4. A probiotic formulation containing Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 was associated with reduced urinary free cortisol in human subjects in a study by Messaoudi M et al. published in the British Journal of Nutrition (2011) (5).
  5. Butyrate, a short-chain fatty acid produced by gut microbiota, may support brain-derived neurotrophic factor (BDNF) expression and blood-brain barrier integrity, according to Bourassa MW et al. in Neuroscience Letters (2016) (13).
  6. Immune-driven activation of the kynurenine pathway via indoleamine 2,3-dioxygenase (IDO) may divert tryptophan away from serotonin synthesis and toward quinolinic acid production, a process associated with neuroinflammation, as reviewed by Schwarcz R et al. in Nature Reviews Neuroscience (2012) (12).

Support Your Mood From the Gut Up

If persistent anxiety, low mood, or brain fog coincides with digestive symptoms, the gut-brain axis may be playing a larger role than you realise. At Elemental Health and Nutrition, we take a functional medicine approach to identify whether microbial imbalance, immune activation, or neurotransmitter disruption is contributing to your symptoms — and develop targeted strategies to address it.

Book an Appointment

References

  1. Dinan TG et al. Psychobiotics: a novel class of psychotropic. Biol Psychiatry. 2013 Nov 15;74(10):720-6. https://doi.org/10.1016/j.biopsych.2013.05.001
  2. Pinto-Sanchez MI et al. Probiotic Bifidobacterium longum NCC3001 reduces depression scores and alters brain activity: a pilot study in patients with irritable bowel syndrome. Gastroenterology. 2017 Nov;153(5):1354-1366.e4. https://doi.org/10.1053/j.gastro.2017.08.003
  3. Cryan JF et al. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 2012 Oct;13(10):701-12. https://doi.org/10.1038/nrn3346
  4. Bravo JA et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression via the vagus nerve. Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):16050-5. https://doi.org/10.1073/pnas.1102999108
  5. Messaoudi M et al. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr. 2011 Mar;105(5):755-64. https://doi.org/10.1017/S0007114510004319
  6. Sudo N et al. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol. 2004 May 1;558(Pt 1):263-75. https://doi.org/10.1113/jphysiol.2004.063388
  7. Desbonnet L et al. The probiotic Bifidobacterium infantis: an assessment of potential antidepressant properties in the rat. J Psychiatr Res. 2008 Dec;43(2):164-74. https://doi.org/10.1016/j.jpsychires.2008.03.009
  8. Akkasheh G et al. Clinical and metabolic response to probiotic administration in patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial. Nutrition. 2016 Mar;32(3):315-20. https://doi.org/10.1016/j.nut.2015.09.003
  9. Stilling RM et al. Friends with social benefits: host-microbe interactions and brain development. Front Cell Neurosci. 2016 Nov 18;10:265. https://doi.org/10.3389/fncel.2016.00265
  10. Wallace CJK et al. The effects of probiotics on depressive symptoms in humans: a systematic review. Ann Gen Psychiatry. 2017 Feb 20;16:14. https://doi.org/10.1186/s12991-017-0138-2
  11. Porges SW. The polyvagal theory: neurophysiological foundations of emotions, attachment, communication, and self-regulation. New York: W. W. Norton & Company; 2011.
  12. Schwarcz R et al. Kynurenines in the mammalian brain: physiology and pathology. Nat Rev Neurosci. 2012 Jul 18;13(8):535-48. https://doi.org/10.1038/nrn3257
  13. Bourassa MW et al. Butyrate, neuroepigenetics and the gut microbiome: can a high fiber diet improve brain health? Neurosci Lett. 2016 Jun 20;625:56-63. https://doi.org/10.1016/j.neulet.2016.02.038
  14. O’Mahony SM et al. Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav Brain Res. 2015 Feb 15;277:32-48. https://doi.org/10.1016/j.bbr.2014.07.027
  15. Sarkar A et al. Psychobiotics and the manipulation of bacteria-gut-brain signals. Trends Neurosci. 2016 Nov;39(11):763-781. https://doi.org/10.1016/j.tins.2016.09.002

Ready to find answers?

Stop surviving. Start recovering.

Similar Posts